Luz Saúde SA

11/21/2023 | Press release | Distributed by Public on 11/21/2023 05:05

Pedro Aragão launches new consultation at Hospital da Luz Coimbra

Specialist in cardiac arrhythmia and interventional cardiology, he coordinates the Heart Rate Centre of Hospital da Luz Lisboa.

Hospital da Luz Coimbra now has the collaboration of Pedro Adragão, through the provision of a Cardiology - Atrial Fibrillation Consultation. Cardiologist, professor and specialist in clinical arrhythmia and interventional cardiology, he directs the Heart Rate Centre of Hospital da Luz Lisboa.

Through his clinical practice of electrophysiology or under his supervision, Pedro Aragão was responsible for the introduction in Portugal of a number of diagnostic and therapeutic techniques, which have allowed to approach cardiac arrhythmia in a less invasive and faster manner, with no complications for patients.

Atrial fibrillation - or cardiac arrhythmia - is the most prevalent cardiac rhythm alteration, being associated with age: after 50, the incidence rate doubles for every decade of life. Moreover, atrial fibrillation is associated with concomitant diseases, such as for instance:

  • Arterial hypertension;
  • Diabetes;
  • Sleep apnea;
  • Cardiac insufficiency;
  • Valvular disease;
  • Coronary disease;
  • Smoking.

One of the possible treatments for atrial fibrillation is catheter ablation, which has proven to be the most efficient: recent studies show that, besides controlling symptoms, it also contributes to reduce mortality, the risk of cerebrovascular accident and dementia. Atrial fibrillation ablation is a proficient treatment, by:

  • Allowing a sustained conversion to normal rhythm;
  • Promoting a reduction of the adverse consequences of cardiac dysrhythmia, that is undoubtedly a pandemic of modern times.

The Heart Rate Centre of Hospital da Luz Lisboa, coordinated by Pedro Aragão, has already treated over four thousand patients with complex arrhythmias. Presently, it is the second largest centre in the world, in the treatment of these diseases by robotic ablation.